Distinct effects of leukocyte and cardiac phosphoinositide 3-kinase γ activity in pressure overload-induced cardiac failure.
about
Phosphoinositide 3-kinase: friend and foe in cardiovascular diseaseNADPH oxidases in heart failure: poachers or gamekeepers?Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of CardiologyPI3Kγ in hypertension: a novel therapeutic target controlling vascular myogenic tone and target organ damageThe Multifaceted Roles of PI3Kγ in Hypertension, Vascular Biology, and InflammationDeep RNA sequencing reveals novel cardiac transcriptomic signatures for physiological and pathological hypertrophyLack of kinase-independent activity of PI3Kγ in locus coeruleus induces ADHD symptoms through increased CREB signaling.Stressed hearts inflame the body (in a good way).IQGAP1 regulates ERK1/2 and AKT signalling in the heart and sustains functional remodelling upon pressure overload.In search of new therapeutic targets and strategies for heart failure: recent advances in basic scienceTetrahydrobiopterin Protects Against Hypertrophic Heart Disease Independent of Myocardial Nitric Oxide Synthase Coupling.Specific PI3K isoform modulation in heart failure: lessons from transgenic mice.Therapeutic applications of PI3K inhibitors in cardiovascular diseases.The role of B-cells in heart failurePI3K in cancer-stroma interactions: bad in seed and ugly in soil.Myocyte signalling in leucocyte recruitment to the heart.Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling.An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy.Akt activation by PHLPP1 ablation prevents pathological hypertrophy by promoting angiogenesis.Inflammatory Mediators Drive Adverse Right Ventricular Remodeling and Dysfunction and Serve as Potential Biomarkers.PI3Kγ inhibition reduces blood pressure by a vasorelaxant Akt/L-type calcium channel mechanismCardiomyocytes and Macrophages Discourse on the Method to Govern Cardiac Repair
P2860
Q26796228-49E7D338-2D2A-4E64-ACF5-A70F23B0A10CQ27001094-D71ABD97-E30E-4306-B95C-37E214E176EDQ27024879-C14A75F2-06AD-4997-A7C3-CF10835B4C89Q27026365-45A2D03A-C1BD-42A3-8E70-98863B780EE0Q28066576-5AB31F53-1785-4F23-90C1-E615CBA9F955Q34241891-A4B4CDDC-F92D-4892-B93D-E0BF1E47E2DCQ35604751-2C87BE1D-6EE7-4B32-8053-0D45AD037DC2Q35740357-1D0FB41D-5B4E-42CC-AD87-8B00740292D0Q35804062-647D8FCD-8194-44E0-B847-2259F7AE315AQ36364300-EF213FE6-CC37-4DE3-BFA9-42C62CDC1C6DQ37090886-3DC4D083-EC22-4A59-B525-3EF0A0FA50D4Q37868990-3E646785-7537-41A7-8283-6FB19CDF8828Q38089742-3059BAEF-784B-4B71-BBBC-18A43C2672A0Q38091933-4B98009C-0EC4-45EB-96E0-6A7092D4A7FEQ38124762-9CD5FBEA-FEA4-4A7A-B510-46A697717433Q38185647-3CC52D37-C378-4D05-BB20-30A3210123C8Q38380871-28F06721-E1A7-4F8B-8C48-2C5BAD8037E6Q39232014-79DC03CB-22B1-4979-90BA-947ADB02520DQ55069112-66898501-1BA9-4153-A144-F4151D980BE3Q55155611-72932688-37CB-4D37-93FA-9E416DA2BAD5Q57005928-853E841F-0840-43E7-8461-69248ECCB351Q58586099-86A50844-E16D-40EE-B23F-189418915E0B
P2860
Distinct effects of leukocyte and cardiac phosphoinositide 3-kinase γ activity in pressure overload-induced cardiac failure.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Distinct effects of leukocyte ...... rload-induced cardiac failure.
@en
Distinct effects of leukocyte ...... rload-induced cardiac failure.
@nl
type
label
Distinct effects of leukocyte ...... rload-induced cardiac failure.
@en
Distinct effects of leukocyte ...... rload-induced cardiac failure.
@nl
prefLabel
Distinct effects of leukocyte ...... rload-induced cardiac failure.
@en
Distinct effects of leukocyte ...... rload-induced cardiac failure.
@nl
P2093
P50
P1433
P1476
Distinct effects of leukocyte ...... rload-induced cardiac failure.
@en
P2093
Alessia Perino
Federico Damilano
Katrin Schaefer
Ornella Azzolino
P304
P356
10.1161/CIRCULATIONAHA.110.950543
P407
P50
P577
2011-01-17T00:00:00Z